Your Article Summary
See Latest ArticlesNifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
The Lancet - Early Online Publication, 06/25/09
Priotto G et al. - The efficacy of NECT is non-inferior to that of eflornithine monotherapy. Since this combination treatment also presents safety advantages, is easier to administer (ie, infusion every 12 h for 7 days vs every 6 h for 14 days), and potentially protective against the emergence of resistant parasites, it is suitable for first-line use in HAT control programmes.
Related Articles
Cerebrospinal fluid B lymphocyte identification for diagnosis and follow-up in human African trypanosomiasis in the field
Tropical Medicine & International Health, 10/08/09
Relevance Score: 84%
Human African trypanosomiasis
The Lancet - Early Online Publication, 10/14/09
Relevance Score: 82%
Shifting priorities in vector biology to improve control of vector-borne disease
Tropical Medicine & International Health, 10/08/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09
Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09
'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09